Back to Market Feed

OZEMPIC 2 MG/DOSE (8 MG/3 ML) PEN

semaglutide
$331.9570per ML

Strength

2.68 mg/mL

Manufacturer

Novo Nordisk

NDC

00169477212

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

SEMAGLUTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA209637

On Market Since

4/25/2022

Pharmacological Classes

GLP-1 Receptor Agonist
Glucagon-Like Peptide 1
Glucagon-like Peptide-1 (GLP-1) Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.0%

1Y

+3.4%

3Y

+10.7%

5Y

N/A

All

+16.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

RYBELSUS 3 MG TABLET
Brand
00169430330•Novo Nordisk
$33.1602
per EA
RYBELSUS 14 MG TABLET
Brand
00169431430•Novo Nordisk
$33.1671
per EA
RYBELSUS 7 MG TABLET
Brand
00169430730•Novo Nordisk
$33.1730
per EA
SOLIQUA 100 UNIT-33 MCG/ML PEN
Brand
00024576105•Sanofi-Aventis U.S. LLC
$57.0731
per ML
XULTOPHY 100 UNIT-3.6 MG/ML PEN
Brand
00169291115•Novo Nordisk
$85.8558
per ML
SAXENDA 18 MG/3 ML PEN
Brand
00169280015•Novo Nordisk
$87.1538
per ML
VICTOZA 2-PAK 18 MG/3 ML PEN
Brand
00169406012•Novo Nordisk
$87.7373
per ML
VICTOZA 3-PAK 18 MG/3 ML PEN
Brand
00169406013•Novo Nordisk
$87.8351
per ML
BYETTA 10 MCG DOSE PEN INJ
Brand
00310652401•AstraZeneca Pharmaceuticals LP
$340.1014
per ML
TRULICITY 1.5 MG/0.5 ML PEN
Brand
00002143480•Eli Lilly and Company
$487.6298
per ML